Evidence for an enzymatic defect in the 4-hydroxylation of debrisoquine by human liver.
Open Access
- 1 January 1981
- journal article
- Published by Wiley
- Vol. 11 (1) , 89-91
- https://doi.org/10.1111/j.1365-2125.1981.tb01108.x
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Deficient metabolism of debrisoquine and sparteineClinical Pharmacology & Therapeutics, 1980
- Pharmacogenetic covariation of defective N-oxidation of sparteine and 4-hydroxylation of debrisoquineEuropean Journal of Clinical Pharmacology, 1980
- Monooxygenase activity of human liver in microsomal fractions of needle biopsy specimens.Published by Wiley ,1980
- Toxicological Implications of Polymorphic Drug MetabolismPublished by Wiley ,1980
- Biphasic Michaelis-Menten kinetics for ethoxycoumarin and phenacetin metabolism by human and rat hepatic monooxygenases [proceedings].1979
- Polymorphism of carbon oxidation of drugs and clinical implications.BMJ, 1978
- POLYMORPHIC HYDROXYLATION OF DEBRISOQUINEThe Lancet, 1977
- POLYMORPHIC HYDROXYLATION OF DEBRISOQUINE IN MANThe Lancet, 1977
- Determination of debrisoquin and its 4-hydroxy metabolite in plasma by gas chromatography/mass spectrometryAnalytical Chemistry, 1976